Pacific Biosciences of California, Inc. (PACB)
2.33
+0.03
(+1.30%)
USD |
NASDAQ |
Oct 09, 16:00
2.325
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California Cash from Operations (Quarterly) : -35.58M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -35.58M |
| March 31, 2026 | -44.69M |
| December 31, 2025 | -19.07M |
| September 30, 2025 | -18.71M |
| June 30, 2025 | -29.38M |
| March 31, 2025 | -44.06M |
| December 31, 2024 | -30.65M |
| September 30, 2024 | -45.46M |
| June 30, 2024 | -54.26M |
| March 31, 2024 | -75.68M |
| December 31, 2023 | -57.61M |
| September 30, 2023 | -65.67M |
| June 30, 2023 | -48.58M |
| March 31, 2023 | -94.69M |
| December 31, 2022 | -60.57M |
| September 30, 2022 | -63.05M |
| June 30, 2022 | -60.56M |
| March 31, 2022 | -79.03M |
| December 31, 2021 | -31.71M |
| September 30, 2021 | -40.66M |
| June 30, 2021 | -15.71M |
| March 31, 2021 | -23.10M |
| December 31, 2020 | -14.26M |
| September 30, 2020 | -17.81M |
| June 30, 2020 | -23.79M |
| Date | Value |
|---|---|
| March 31, 2020 | 75.36M |
| December 31, 2019 | -18.18M |
| September 30, 2019 | -17.26M |
| June 30, 2019 | -17.56M |
| March 31, 2019 | -25.31M |
| December 31, 2018 | -18.98M |
| September 30, 2018 | -14.18M |
| June 30, 2018 | -14.50M |
| March 31, 2018 | -18.77M |
| December 31, 2017 | -20.20M |
| September 30, 2017 | -17.84M |
| June 30, 2017 | -12.81M |
| March 31, 2017 | -16.67M |
| December 31, 2016 | -12.90M |
| September 30, 2016 | -15.88M |
| June 30, 2016 | -18.88M |
| March 31, 2016 | -20.27M |
| December 31, 2015 | -0.714M |
| September 30, 2015 | -15.77M |
| June 30, 2015 | -7.494M |
| March 31, 2015 | -23.91M |
| December 31, 2014 | -15.36M |
| September 30, 2014 | -6.235M |
| June 30, 2014 | -13.62M |
| March 31, 2014 | -16.26M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Illumina, Inc. | 201.00M |
| Danaher Corp. | 1.534B |
| Thermo Fisher Scientific, Inc. | 2.125B |
| Agilent Technologies, Inc. | 519.00M |
| Bio-Rad Laboratories, Inc. | 98.70M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 40.07M |
| Cash from Financing (Quarterly) | 0.255M |
| Free Cash Flow | -130.48M |
| Free Cash Flow Per Share (Quarterly) | -0.1262 |
| Free Cash Flow to Equity (Quarterly) | -41.93M |
| Free Cash Flow to Firm (Quarterly) | -37.08M |
| Free Cash Flow Yield | -18.37% |